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 There has been broad concern that arsenic in the environment exerts neurotoxicity. To determine 
the mechanism by which arsenic disrupts the neuronal development, primary cultured neurons 
obtained from the cerebral cortex of mouse embryos were exposed to sodium arsenite (NaAsO2) 
at concentrations between 0 and 2 PM from day 2 to 4 in vitro and cell survival, neurite outgrowth 
and expression of glutamate AMPA receptor subunits were assessed at day 4 in vitro. Cell survival 
was significantly decreased by exposure to the ȝ0 NaAsO2 concentration, whereas the 0.5 ȝ0 
of NaAsO2 increased cell survival instead. The assessment of neurite outgrowth showed that total 
neurite length was significantly suppressed by 1 ȝ0 and 2 ȝ0 NaAsO2, indicating that the lower 
concentration of NaAsO2 impairs neuritogenesis before inducing cell death. Immunoblot analysis 
of AMPA receptor subunit expression showed that the protein level of GluA1, a specific subunit 
of the AMPA receptor, was significantly decreased by 1 PM and 2 PM NaAsO2. When 
immunocytochemistry was used to confirm this effect by staining for GluA1 expression in 
neuropeptide Y neurons, most of which contain GluA1, GluA1 expression in neuropeptide Y 
neurons was found to be significantly suppressed by 1 µM and 2 µM NaAsO2 but to be increased 
at the 0.5 ȝ0 concentration. Finally, to determine whether neurons could be rescued from the 
NaAsO2-induced impairment of neuritogenesis by compensatory overexpression of GluA1, we 
used primary cultures of neurons transfected with a plasmid vector to overexpress GluA1, and the 
results showed that GluA1 overexpression protected against the deleterious effects of NaAsO2 on 
neurite outgrowth. These results suggest that, 1) the toxic concentrations of NaAsO2 in regard to 
cell survival, neurite outgrowth and GluA1 expression differ, 2) the NaAsO2 concentration that 
induces neurite suppression is lower than the concentration that induces cell death and is almost 
the same as the concentration that suppresses GluA1 expression, and 3) the suppression of GluA1 




 The developing brain is vulnerable to toxic chemical compounds during gestation and early 
childhood, and exposure to them permanently affects brain functions (Costa et al., 2004; 
Grandjean and Landrigan, 2006). Heavy metals and persistent organic pollutants have been 
shown to be toxic to the developing brain epidemiologically and empirically (Winneke, 2011). 
Two heavy metals, inorganic lead and methylmercury are notorious causative agents that are 
responsible for the increased prevalence of mental retardation,! cerebral palsy, autism, and 
attention-deficit hyperactivity disorder (ADHD) in children (Goulet et al., 2003; Costa et al., 
2004; Farina et al., 2011; Winneke, 2011). Another metal, arsenic may also have neurotoxic 
effects on development. Follow-up studies of the victims of arsenic poisoning in the Morinaga 
milk incident in Japan have shown that the oral exposure to arsenic during infancy increases the 
prevalence of brain disorders, including mental retardation and epilepsy (Dakeishi et al. 2006). 
Additional evidence of the arsenic neurotoxicity was obtained in an epidemiological study of 
Mexican children living near a smelter demonstrated an inverse correlation between the 
FKLOGUHQ¶VXrinary arsenic levels and their verbal intelligence quotients. (Calderón J et al., 2001). 
Epidemiological studies from Bangladesh, China and Taiwan have shown that chronic exposure 
to drinking water containing arsenic decreased the cognitive performance of children (Wang et al., 
2007; Hamadani et al., 2011; Wasserman et al., 2004, 2007; Tsai et al., 2003), suggesting that 
arsenic has toxic effects on the central nervous system not only in the form of an industrial 
pollutant but also as an environmental contaminant of drinking water and food.  
Empirical studies have been performed on experimental animals to determine how arsenic 
exposure impairs normal brain development. Rats and mice exposed to arsenic during gestation 
and early childhood exhibit behavioral deficits such as changes in locomotor activity, learning, 
memory, depression-like behavior and neuromotor reflex (Rodríguez et al., 2002, Xi et al., 2009, 
Martinez-Finley et al. 2009). The behavioral changes caused by arsenic seem to be accompanied 
by neurochemical abnormalities and loss of nerve fibers (Nagaraja and Desiraju, 1993; Martinez 
et al. 2008; Ríos et al., 2009). The inhibitory effects of arsenic on neuritogenesis have been 
monitored in in vitro experiments, and the results have been consistent with the results observed 
in animals in vivo. Studies conducted on immortalized cell lines have shown that arsenic impairs 
neurite outgrowth and complexity (Frankel et al., 2009). Arsenic is known to exert its neurotoxic 
effects by inducing apoptotic cell death as well as the inhibition of neuritogenesis (Koike-Kuroda 
et al., 2010). We recently reported finding that neurite elongation in the Neuro2A cell line was 
suppressed by sodium arsenite at a lower concentration than the concentration that induced 
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apoptosis (Aung et al., 2013). Thus, neuritogenesis would seem to be more sensitive to arsenic 
toxicity than cell viability is. Arsenic may exert its toxic effect through several different 
mechanisms, including at least the different mechanisms that are responsible for the suppression 
of neurite growth and for the induction of apoptosis, but the mechanisms are not completely 
understood. 
  Glutamate transmission plays essential roles in a variety of brain functions and in the 
development. AMPA receptors, a major subtype of glutamate receptors, are composed of four 
types of different subunits, i.e., GluA1, 2, 3 and 4, and play a critical role in excitatory glutamate 
transmission (Kumar and Mayer, 2012). AMPA receptors are also involved in the formation of 
neuronal networks and connectivity. Pharmacological potentiation of AMPA receptors and 
overexpression of either AMPA receptor subunit GluA1 or GluA2 by transient transfection 
promotes neurite outgrowth (Voss et al., 2007; Prithviraj et al., 2008; Chen et al., 2009). These 
results suggest that modifications of AMPA receptor subunit expression and subsequent increases 
in excitability due to enhanced glutamate transmission are closely related to the regulation of 
neuritogenesis.  
 In the present study, we investigated the effects of arsenic on AMPA receptors in primary 
cultures of mouse cortical neurons to determine the mechanism by which arsenic exposure 
suppresses neuritogenesis. Immunoblot and immunocytochemistry analyses showed that arsenic 
suppressed the level of GluA1 expression in parallel with the suppression of neurite outgrowth. 
We also transfected GluA1 into primary neurons with plasmid vectors to determine whether 
overexpression of AMPA receptors would rescue the neurite outgrowth suppressed by arsenic. 
 
2. Materials and Methods 
!"#$%&'($
 Male and female C57BL/6J mice were purchased from CLEA Japan (Tokyo, Japan) and were 
bred in National Institute for Environmental Studies. They were acclimatized to the environment 
for about 1 week prior to use. Throughout the experiment, animals were maintained in a 
controlled environment at a temperature of 24 ± 1 oC and humidity of 50 ± 10% and under a 12/12 
h light/dark cycle (light, ZT0±12; dark, ZT12±24). Food (CE-2, CLEA) and water were available 
ad libitum unless otherwise indicated. Adult males and females were kept in couples to obtain 
pregnant females. Vaginal plug was checked each day to estimate the gestational age. 
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!For the experiment focusing on neuropeptide Y (NPY) neurons, NPY-hrGFP transgenic mice 
produced by Prof. Bradford B. Lowell (Beth Israel Deaconess Medical Center) were purchased 
from the Jackson Laboratory (B6.FVB-Tg(Npy-hrGFP)1Lowl/J, Stock#006417, Bar Harbor, 
ME) (van den Pol et al., 2009). Adult males and females were genotyped by multiplex PCR of 
tail-derived DNA using the following three different primers: TAT GTG GAC GGG GCA GAA 
GAT CCA GG, CCC AGC TCA CAT ATT TAT CTA GAG, and GGT GCG GTT GCC GTA CTG 
GA. The PCR was performed using KOD dash (Toyobo, Tokyo, Japan) according to the 
PDQXIDFWXUHU¶V LQVWUXFWLRQ 7KH 3&5 UHDFWLRns were performed using the following cycle 
conditions: 1) 94 °C for 3 min, 2) 35 cycles of 94 °C for 30 s, 58.5 °C for 5 s, and 74 °C for 30 s, 
and 3) 74 °C for 7 min. PCR products were subjected to electrophoresis on a 1.5 % agarose gel 
and the insertion of transgene was determined by the appearance of band sizes (transgene, 400 bp, 
and internal positive control, 500 bp). For culture of primary NPY-hrGFP neurons, the brain at 
embryonic day 17 was obtained and the green fluorescence in the cerebral cortex observed with 
either IX70 fluorescence microscope (Olympus, Tokyo, Japan) or BioRevo BZ-9000 (Keyence, 
Osaka, Japan).  
 
2.2 Ethics Statement 
Mice were handled in a humane manner in accordance with the National Institute for 
Environmental Studies guidelines. 
 
2.3 Primary culture of neurons and transfection of plasmids 
 Primary cultures of mouse cortical neurons were prepared following the method described 
previously (Chenal and Pellerin, 2007) with slight modifications. Briefly, the pregnant mouse at 
embryonic day 17 was sacrificed by decapitation and the cerebral cortices of embryos were 
collected under dissection microscope. The cortices were washed with 10 mM HEPES-buffered 
Krebs-Ringer bicarbonate buffer (HKRB) containing 10 mM glucose. They were incubated in 
HKRB supplemented with 20 U/ml papain (Sigma Chemical Co., St. Louis, MO), 0.015 mg/ml 
deoxyribonuclease (Sigma), 0.75 mg/ml bovine serum albumin (Sigma) and 1 mM cysteine 
(Sigma) for 10 min at 37 °C in a shaking water bath, followed by gentle mechanical trituration. 
The subsequent cell suspension was centrifuged at 100 ! g for 5 min and the cell pellet collected. 
In the case that transfection of plasmids was required, we used the Amaxa Nucleofector with 
mouse neuron nucleofector® kit (#VPG-1001, Lonza, Basel, Switzerland) following 
PDQXIDFWXUHU¶VLQVWUXFWLRQ)RUWUDFLQJQHXULWHs, we used the pmStrawberry plasmid expressing 
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red fluorescent protein mStrawberry under the control of CMV promoter (Maekawa et al. 2009) 
in Fig. 1 B-I, Fig. 4, and Supplementary Fig.1. For overexpressions of GluA1 and 2, we used 
pGFP-GluA1 expressing GFP-fused GluA1 under the control of CMV promoter (kindly provided 
by Dr. Jeremy M. Henley, University of Bristol) and pVenus-GluA2 expressing GluA2-fused with 
Venus, a GFP variant, under the control of CMV promoter. Correct band sizes and surface 
expressions of fused proteins in primary cultures of neurons have been already determined 
previously (Perestenko and Henley, 2003; Maekawa et al., 2009). We used pEGFP (Clontech, 
Takara, Japan) expressing GFP as a control instead of pGFP-GluA1 and pVenus-GluA2. Cells 
undergoing or not transfection were resuspended in Neurobasal medium (Invitrogen, Carlsbad, 
CA) containing B-27 supplement (50!, Invitrogen), 0.5 mM L-glutamine (Invitrogen) and 
antibiotics (Pen/Strep, #15140-148, 100!, Invitrogen).!Cells were seeded onto poly-L-ornithine 
(15 mg/L)-precoated coverslips (12 mm, Matsunami glass, Osaka, Japan) in 24 wells cell culture 
plates (Falcon, Becton Dickinson AG, Basel, Switzerland). Sodium arsenite (NaAsO2) was added 
on the 2nd day in vitro (DIV2) and maintained up to DIV4 at different concentrations. 
 
2.4 Cell survival assay 
 The effect of NaAsO2 on cell survival of neurons was determined using a colorimetric assay 
based on the reduction of tetrazolium salt to formazan by mitochondrial dehydrogenase activity. 
Ten microliters of Tetrazolium reagent WST-1 (Roche, Switzerland) was then reacted with the 
cells at DIV4 for 1 h at 37 °C, and absorbance at 450 nm was then measured using a reference 
wavelength of 650 nm. The absorbance at 650 nm was subtracted from the absorbance at 450 nm, 
and this value was then expressed as a percentage of the value obtained for the neurons without 
NaAsO2 exposure, whose viability was set at 100%. 
 
2.5 Quantification of neurite outgrowth 
 At DIV4, cells were fixed with ice-cold 4% paraformaldehyde-phosphate buffered saline (PBS) 
for 30 min and washed with PBS. Coverslips were mounted with Vectashield Hard set with DAPI 
(H-1500, Vector Laboratories, Burlingame, CA). Images were taken with a Leica TCS SP5 
AOBS!filter free spectral confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany). 
In Fig. 1 B-I, Fig. 4 and Supplementary Fig. 1, to trace neurites, the fluorescence of pmStrawberry 
was detected according to a previous report (Maekawa et al, 2009). Concerning the NPY-hrGFP 
neurons in Fig. 3 D-H, the fluorescence of hrGFP was detected following the setting of GFP 
(Maekawa et al, 2009). Full optical sections of cells were made by capturing Z-series with one 
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micrometer steps. The integrated image constructed from optical sections in order to define the 
details of neurites was made with Leica Application Suite-Advanced Fluorescence (LAS-AF, 
Version 1.8.2 build 1465, Leica). The images of either red or green channel from the integrated 
image were extracted to visualize either pmStrawberry or hrGFP, respectively, and was converted 
to gray scale to further assessment. The total length of neurites and the number of branches were 
examined by using the software NeuronJ (Meijering et al., 2004) which is a plug-in of ImageJ 
(NIH, Bethesda, MD). NHXULWHV ZHUH FDWHJRUL]HG DV ³SULPDU\´ ZKLFK are neurites directly 
extending from cell body or ³VHFRQGDU\ DQG KLJKHU RUGHU´ ZKLFK are all neurites except 
³SULPDU\´. The number of branches was counted following this categorization. For representative 
presentations in figures, the images inverted black with white were used for legibility. 
 
2.6 Glutamate assay 
 To detect glutamate in culture medium, the glutamate research ELISA kit (#BA E-2300, LDN, 
1RUGKRUQ*HUPDQ\ZDVXVHGIROORZLQJPDQXIDFWXUHU¶VLQVWUXFWLRQ6LPXOWDQHRXVO\WKHamount 
of proteins in each culture well was determined with a BCA protein assay kit (Thermo Fisher 
Scientific, Yokohama, Japan) and glutamate levels corrected for protein level in each well. 
 
2.7 Western blotting 
 Western blotting was carried out as described previously (Maekawa et al. 2009) with a minor 
modification. Briefly, cells were lysed in 0.5% Triton X-100 lysis buffer (50mM Tris-HCl, 150 
mM NaCl, 5mM EDTA) containing proteinase inhibitors (1.9 mg/ml aprotinin, 10 mg/ml 
leupeptin, 100 mM sodium orthovanadate and 200 mM phenylmethylsulfonyl fluoride). The 
protein concentration of lysate was determined with a BCA protein assay kit and the value was 
used for equilibrating the protein level of each lane for SDS-PAGE. After boiling with SDS 
sample buffer (50mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 100mM DTT, 0.001% 
bromphenol blue), the samples were subjected to SDS-PAGE and then transferred to PVDF 
membranes (Hybond-P, Thermo Fisher Scientific). The membranes were blocked by 1% 
casein-PBS for 1 hr and allowed to react with anti-GluA1 (1:1,000, AB1504, Millipore), 
anti-GluA2/3 (1:1,000, AB1506, Millipore), and anti-GluA4 (1:1,000, AB1508, Millipore), and 
anti-E-actin (1:5,000, Sigma-Aldrich) overnight at 4 °C, washed, and then allowed to react with 
horseradish peroxidase-conjugated secondary antibody (anti-rabbit IgG or anti-mouse IgG1) for 1 
hr at room temperature. After washing, membranes were developed using the ECL Plus Western 
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Blotting Detection System (Thermo Fisher Scientific). Band density of each well was determined 
with ImageJ. 
 
2.8 Immunocytochemistry and assessment of relative intensity of fluorescence 
 After fixating with ice-cold 4% paraformaldehyde-PBS and rinsing in PBS, cells were incubated 
with 1% casein-PBS for 1 hr at room temperature in order to block non-specific binding of 
antibody. Next, cells were incubated with rabbit anti-GluA1 (1:100), anti-GluA2/3 (1:100), and 
anti-GluA4 (1:100) in 1% casein-PBS for 24 hrs. After further washing with PBS, cells were 
incubated with AlexaFluor 594-labeled donkey anti-rabbit IgG (1:200, A21207, Invitrogen) for 2 
hrs at 37 °C. After washing again with PBS, cells were examined with confocal microscope. The 
number of GluA1-positive neurons among NPY-hrGFP neurons was manually counted by using 
the integrated images of neurons without treatment with NaAsO2. Relative intensity of GluA1 
immunofluorescence was calculated in the area delineating the cell body of NPY-hrGFP neurons 
with or without treatment with NaAsO2 by using LAS-AF. 
 
2.9 Statistical analyses 
 Data are expressed as mean ± S.E.M. Replicates are indicated in parentheses. All data except Fig. 
2E were analyzed by one-ZD\$129$IROORZHGE\)LVKHU¶Vpost-hoc least significant difference 
using R (The R Foundation for Statistical Computing, Vienna, Austria). Data in Fig. 2E were 
analyzed by Student¶V t-test with Microsoft Excel 2008 for Mac (Microsoft, Redmond, WA). 
Differences were considered significant for p< 0.05. 
 
3. Results 
3.1 Effect of NaAsO2 on cell viability and neurite outgrowth 
 To determine the concentrations of NaAsO2 that affect the survival of primary cultured neurons, 
we exposed them to NaAsO2 concentrations of 0, 0.125, 0.25, 0.5, 1, and 2 PM from DIV2 to 4. 
As shown with the cell survival assay using WST-1 on DIV4 neurons, NaAsO2 significantly 
reduced cell viability at the 2PM concentration (Fig. 1A). However, no significant decrease in 
cell viability was observed at concentrations up to 1PM (Fig. 1A). In contrast to the effect of the 
2PM concentration of NaAsO2, the 0.5PM concentration significantly increased the survival of 
primary neurons and the tendency to increase cell survival was also found at the 0.125 PM and 
0.25 PM concentrations.  
 Analysis of the computer-assisted neurite tracings showed a significant reduction in total neurite 
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length per cell at the 1 ȝ0 and 2 ȝ0concentrations of NaAsO2 (Fig. 1F), and the degree of the 
reduction was greater at 2 PM (Fig. 1F). At 0.5 ȝ0 NaAsO2 tended to increase total neurite length, 
but the difference between the effects of the 0 ȝ0 and 0.5 ȝ0 concentrations was not significant. 
 We also counted the number of total, primary, and secondary and higher order branches per cell. 
Although total number of branches tended to decrease as the concentration increased (1.0 PM vs 0 
and 0.5PM, p=0.09), there were no significant differences between the effects of the different 
concentrations on total number of branches or on the number of primary branches (Fig. 1G and H). 
The number of secondary and higher order branches in the group exposed to 1 PM or 2 µM 
NaAsO2 were smaller than they were in the control group, but differences were not  significant 
(Fig. 1I). 
 
3.2 Effect of NaAsO2 on extracellular glutamate levels and on the A MPA receptor 
expression  
 Since excitotoxicity induced by increases in extracellular glutamate levels is known to be 
involved in neurodegenerative diseases (Lau and Tymianski, 2010), we therefore suspected that 
NaAsO2 elicits excitotoxicity by increasing extracellular glutamate levels. Extracellular 
glutamate levels were measured by collecting the culture medium of primary neurons that had 
been exposed to NaAsO2 at concentrations of 0, 0.125, 0.25, 0.5, and 1 PM from DIV2 to 4 (Fig. 
2A). However, no significant differences in glutamate levels were detected, suggesting that 
NaAsO2 does not affect glutamate release by primary cultured cortical neurons. Next, we 
performed an immunoblot analysis to assess the levels of expression of AMPA receptor subunits. 
Cultured neurons were exposed to NaAsO2 at concentrations of 0, 0.5, 1, and 2 PM from DIV2 to 
DIV4, and cell lysates were obtained at DIV4. Immunoblotting with anti-GluA1 antibody showed 
decreased expression of GluA1 in neurons exposed to 1 µM or 2 µM NaAsO2 in comparison with 
neurons exposed to the 0 PM and 0.5 PM concentrations (Fig. 2B), but there were no significant 
difference in E-actin protein levels (Fig. 2B). Quantification of the GluA1/E-actin intensity ratio 
with the ImageJ software program revealed that exposure to NaAsO2 at 1 PM or 2 PM 
significantly reduced GluA1 expression (Fig. 2C). As far as other AMPA receptor subunits are 
concerned, a comparison between neurons exposed to NaAsO2 at concentrations of 0 PM and 1 
PM was performed (Fig. 2D). In this experiment, we first confirmed the decreased GluA1 
expression by the exposure to 1 PM NaAsO2. Immunoblotting with anti-GluA2/3 and anti-GluA4 
antibodies revealed no changes in GluA2/3 and GluA4 levels as a result of exposure to 1 PM 
NaAsO2, suggesting that NaAsO2 affects the expression of glutamate AMPA receptors in a 
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subunit-specific manner. Since we previously showed that NaAsO2 has no significant effect on 
the mRNA levels of microtubule associated protein-2 (MAP2) and E-actin (Aung et al., 2013), we 
measured the protein levels of MAP2 and E-actin as negative controls in this study. As expected, 
there was no difference in their expression according to whether the cells had been exposed to 1 
µM NaAsO2 or not (Fig. 2D). Quantification of band density confirmed that exposure to 1 PM 
NaAsO2 significantly reduces of GluA1 expression but does not reduce expression of any of the 
other subunits (Fig. 2E). 
 
3.3 Effect of NaAsO2 on GluA1 expression in primary cultured NPY-hr G FP neurons 
To confirm the results of the immunoblot analyses showing that NaAsO2 suppresses the GluA1 
level by a different approach, we used primary cultures prepared from transgenic mice that 
express a humanized Renilla green fluorescence protein under the control of a neuropeptide Y 
gene promoter (NPY-hrGFP). The cerebral cortex emitting green fluorescence could be observed 
in the macroview of the mouse brain at embryonic day 17 by using BioRevo BZ-9000 (Fig. 3A). 
We easily identified NPY-hrGFP neurons in primary cultures of cortical neurons, because their 
cell bodies and neurites emitted green fluorescence (Fig. 3B). Immunofluorescence staining with 
anti-GluA1 antibody revealed that at DIV4 98.5% of the NPY-hrGFP neurons were 
GluA1-positive under our culture conditions (Fig. 3B and 3C). Before examining GluA1 levels, 
we checked to see whether neurite outgrowth of NPY-hrGFP neurons could be suppressed in a 
similar manner as that shown in Fig. 1. The results of exposure to NaAsO2 concentrations of 0, 
0.5, 1 and 2 PM showed that neurite elongation was reduced when exposed to the 1 PM 
concentration and that the reduction became greater at the 2 PM concentration (Fig. 3D-H), 
indicating that the NaAsO2 concentrations that reduced neurite outgrowth by NPY-hrGFP 
neurons were the same as those presented in Fig. 1F. Using the same paradigm of NaAsO2 
treatment, we measured the immunoflurescent intensity of GluA1 and GluA4 in NPY-hrGFP 
neurons. The relative intensity of fluorescence using anti-GluA1 antibody was significantly 
higher in neurons exposed to 0.5 PM NaAsO2 than to other concentrations (Fig. 3I). By contrast, 
1 PM NaAsO2 reduced the intensity of the GluA1-immunofluorescent signal and 2 PM NaAsO2 
reduced its intensity even more. These results suggested the existence of a relation between the 
reduction in GluA1 expression level and neurite suppression. On the other hand, the intensity of 
the GluA4-immunofluorescent signal increased with the concentration of NaAsO2 (Fig. 3J), 
confirming that NaAsO2 specifically reduces GluA1 expression and does not reduce GluA4 
expression. We also investigated the effects of NaAsO2 on GluA2/3 by immunofluorescent 
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staining with an anti-GluA2/3 antibody, but the immunofluorescent signal for GluA2/3 was weak 
at DIV4, and there was no marked difference in GluA2/3 immunofluorescent intensity according 
to whether the cells had been exposed to NaAsO2 or not (data not shown).  
 
3.4 Effects of G luA1 and GluA2 overexpression on impaired neurite outgrowth 
  To determine whether overexpression of exogenous AMPA receptor subunits could compensate 
for the decreased GluA1 expression induced by NaAsO2 and rescue the inhibitory effect of 
NaAsO2 on neurite outgrowth, primary cultured neurons prepared from mouse cerebral cortex 
were transfected with a plasmid vector to express GFP-fused GluA1 (pGFP-GluA1) or 
Venus-fused GluA2 (pVenus-GluA2) under the control of a CMV promoter in combination with 
pmStrawberry and then exposed to 2 PM NaAsO2 from DIV2 to DIV4 (Fig. 4A-D). A pEGFP 
plasmid vector was used to express GFP was used instead of the GluA1 and GluA2 expression 
vectors. Neurite outgrowth by the neurons transfected with the control vector expressing GFP was 
strongly inhibited by 2 PM NaAsO2 (Fig. 4C), whereas neurite outgrowth was stimulated by 
GluA1 overexpression (Fig. 4B), and its overexpression mitigated the inhibitory effect of 
NaAsO2 on neurite outgrowth (Fig. 4D). Quantification of total neurite length also demonstrated 
that 2 PM NaAsO2 significantly reduced the total neurite length of neurites in neurons in the 
absence of GluA1 overexpression and that the inhibition of neuritogenesis by NaAsO2 was 
prevented by GluA1 overexpression (Fig. 4E). Exposure to 2 PM NaAsO2 significantly reduced 
the total number of branches in both the presence and absence of GluA1 overexpression (Fig. 4F). 
In contrast to its rescuing effect on total neurite length, overexpression of GluA1 did not 
overcome the significant effect of NaAsO2 on total branch number (Fig. 4F). No significant 
differences were observed in number of primary branches (Fig. 4G). The numbers of secondary 
and higher order branches were significantly increased by GluA1 overexpression in the absence 
of NaAsO2 exposure (Fig. 4H), but their numbers remained low after exposure to NaAsO2 even 
though GluA1 was overexpressed (Fig. 4H).  
 GluA2 overexpression had effects on neurite length and the number of branches that were 
similar to the effects of GluA1 overexpression (Supplementary Fig. S1A-H). The results of 
GluA2 overexpression are shown in detail in the supplementary text. 
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4. Discussion 
 Neuritogenesis in our primary culture of mouse cortical neurons was impaired by exposure to 
NaAsO2 concentrations of 1 PM or above, and NaAsO2 exposure to the same concentrations also 
decreased their GluA1 levels. GluA1 overexpression blocked the inhibition of neurite elongation 
by NaAsO2. These results indicate that the suppression of neurite outgrowth by NaAsO2 may at 
least be partially attributable to reduced glutamate AMPA receptor expression. On the other hand, 
exposure to 0.5 PM NaAsO2, a lower concentration than the concentration that induced neurite 
suppression, increased cell survival and the GluA1 levels according to the immunocytochemistry 
findings.  
 
4.1 A rsenic-induced suppression of neurite outgrowth and reduction of GluA1 expression 
 In this study, 1PM NaAsO2 did not affect cell viability, but strikingly suppressed neurite 
outgrowth. In a previous study we found that lower concentrations of NaAsO2 affected 
neuritogenesis before inducing apoptotic and necrotic cell death (Aung et al., 2013). Studies by 
other groups have shown that neurite damage is a cue for the induction of cell death (Berliocchi et 
al., 2005, Volbracht et al., 2001). Thus, the suppression of neurite outgrowth may be a primary 
step in the developmental neurotoxicity of arsenic. 
 Several hypotheses have been proposed to explain how arsenic suppresses neurite outgrowth. 
Excitotoxicity is caused by excess levels of neurotransmitters, such as glutamate and other 
excitatory transmitters, and has been reported to lead to several neurodegenerative diseases (Lau 
and Tymianski 2010). Since we suspected that excitotoxicity mediates the arsenic-induced neurite 
suppression, we measured the glutamate concentration in culture medium after NaAsO2 exposure. 
Surprisingly, the glutamate concentration in the culture medium was unaltered by NaAsO2 (Fig. 
2A) and thus excitotoxicity may not be the cause of the neurite suppression in our culture system. 
A decrease in the number of glutamate receptor(s) is another possible cause of neurodegenerative 
diseases, because changes in cerebral AMPA receptor expression have been reported in 
neurodegenerative diseases (Optiz et al.,!2000), and AMPA receptor knockdown itself is a cause 
and an aggravating factor of neurodegeneration (Oguro et al., 1999). We performed two 
experiments to test the hypothesis that NaAsO2 suppresses AMPA receptor expression. In the first 
experiment, AMPA receptor protein levels in total cell lysates were measured by immunoblot. 
The results showed that NaAsO2 at concentrations of 1PM and above reduced the GluA1 levels 
and that the reductions paralleled the suppression of neurite elongation. In the second experiment, 
we performed immunocytochemistry on NPY-hrGFP neurons to verify the result of the first 
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experiment. NPY neurons localized mainly in layer II/III and VI of the cerebral cortex (van den 
Pol et al., 2009) are known to be involved in neurological diseases such as epilepsy, schizophrenia, 
depression and ADHD (Lesch et al.,!2011; Brothers and Wahlestedt, 2010; Connor et al., 2011). 
NPY neurons have been reported to function as inhibitory interneurons (Gelman et al., 2011). 
NPY-hrGFP neurons have a great advantage of allow examination of the detailed morphology of 
NPY neurons through green fluorescence without specific staining. Since neurites of NPY-hrGFP 
neurons were as vulnerable to NaAsO2 as the neurites of neurons transfected with pmStrawberry 
(Fig. 3D-H), we concluded that NPY-hrGFP neurons could be used as a typical example of 
cortical neurons in regard to sensitivity to NaAsO2. It is also advantageous to utilize NPY-hrGFP 
neurons when evaluating GluA1 levels, because most NPY-hrGFP neurons exhibited 
GluA1-immunoreactivity in our culture system (Fig.3C). The immunocytochemistry analysis of 
GluA1 in NPY-hrGFP neurons confirmed that NaAsO2 at concentrations of 1PM and above 
reduced GluA1 expression. Based on the consistent results obtained in these two experiments, we 
speculated that reduced GluA1 expression is a factor that links NaAsO2 exposure to impaired 
neurite outgrowth. Since exposing rats to arsenic has been reported to increase the glutamate 
content of their brain (Nagaraja and Desiraju, 1993), the possibility remains that excitotoxicity 
still occurs following arsenic exposure in in vivo. Further study will be necessary to determine 
whether arsenic affects glutamate release and/or glutamate AMPA receptor expression in vivo.  
 Some etiological causes explaining how NaAsO2 reduces GluA1 levels can be proposed. 
Arsenic is known to induce oxidative stress, and oxidative stress leads to the suppression of 
neurite outgrowth and changes in cytoskeletal proteins expression (DeFuria and Shea, 2007; 
Wang et al., 2010). We recently demonstrated that NaAsO2 specifically changed the gene 
expression of cytoskeletal proteins in Neuro2A cells (Aung et al., 2013). Exposure to NaAsO2 
dose-dependently reduced the mRNA levels of tau and tubulin in Neuro2A cells but increased the 
mRNA levels of the light and medium subunits of neurofilaments. Since the intracellular transport, 
synaptic insertion and recycling of GluA1 have been reported to be controlled by cytoskeletal 
proteins (Anggono and Huganir, 2012; Perestenko and Henley, 2003), reduced GluA1 levels may 
be caused by cytoskeletal dysfunction in response to oxidative stress induced by NaAsO2. Apart 
from cytoskeletal dysfunction, epigenetic regulation of GluA1 may be responsible for the 
arsenic-induced suppression of neurite outgrowth. It has been reported that expression of HDAC2, 
a subtype of histone deacetylase sensitive to neurotoxic insults, was found to increase in response 
to oxidative stress and neurotoxic accumulation of E-amyloid, and that the increase reduced gene 
expression of proteins related to synaptic plasticity including GluA1, as a result of deacetylation 
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of histones localized at their promoters (Gräff et al. 2012). Given that arsenic affects HDAC2 
expression through eliciting oxidative stress, GluA1 expression may be reduced by the activity of 
HDAC2. These hypotheses should be tested in future studies. 
 
4.2 Rescue f rom arsenic-induced suppression of neurite outgrowth by overexpression of 
G luA 
 Compensatory overexpression of GluA1 partially reversed the neurite suppression induced by 
2PM NaAsO2 in this study (Fig. 4), thereby indicating that the impaired neurite outgrowth is at 
least partly due to the reduction of the GluA1 expression level. AMPA receptors composed of any 
tetrameric combination of GluA1-4 subunits are permeable to Na+ after glutamate binds to them, 
whereas Ca2+ permeability depends on their subunit composition. AMPA receptors lacking 
GluA2 are Ca2+-permeable, whereas AMPA receptors containing GluA2 are Ca2+-impermeable 
(Hume et al., 1991; Verdoorn et al., 1991). Since overexpression of GluA1 and GluA2 has been 
reported to increase total neurite length by increasing neuronal excitability (Prithviraj et al., 2008, 
Chen et al., 2009), both GluA1 and GluA2 may be associated with neuritogenesis despite the 
difference in Ca2+ permeability. In our case, overexpression of GluA2 as well as GluA1 partly 
reversed the impaired neurite outgrowth (Fig.4 and Supplementary Fig. 1). Therefore, the 
recovery from impaired neurite outgrowth caused by NaAsO2 is likely to be related to the 
increase in neuronal excitability as a result of Na+ entry rather than due to Ca2+ entry. 
 The observation that GluA overexpression rescues neurons from arsenic neurotoxicity implies 
that GluA stimulation by certain drugs may have a therapeutic effect on neurodegeneration 
induced by arsenic. AMPA receptor agonists and modulators, such as ampakines, might be 
candidate drugs for the prevention and/or treatment of arsenic-induced neurodegeneration. 
 
4.3 Effect of low arsenic concentrations on neurons 
 Although exposure to NaAsO2 concentrations of 1 PM and above reduced cell survival, the 0.5 
PM concentration of NaAsO2 had the opposite effect and at rather significantly increased cell 
survival, and immunocytochemistry measurements showed that it tended to increase neurite 
outgrowth and significantly increased GluA1 levels when measured by immunocytochemistry. 
Exposure to arsenic concentrations below the concentration that causes cell death has been 
reported to stimulate keratinocyte proliferation and vascular cell proliferation through 
overexpression of growth factors and activation of tyrosine phosphorylation, respectively 
(Germolec et al., 1996; Barchowsky et al., 1999). We have not yet identified the pathway by 
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which arsenic increases cell survival and GluA1 levels in neurons at concentrations below the 
concentration that suppresses neurite growth. It should be identified in a future study. 
 The occurrence of neurodevelopmental disorders such as autism and ADHD have been 
suspected of being associated with exposure to environmental chemicals, including arsenic 
(Grandjean et al., 2006). Increases in the size of some brain regions and decreases in the size of 
others have been reported in neurodevelopmental disease (Seidman et al. 2011; Bauman and 
Kemper, 2005), and these anomalies might EHUHVSRQVLEOHIRUSDWLHQW¶V cognitive dysfunction. If 
arsenic affects the brain differently depending on its concentration, since great differences in 
arsenic distribution among brain regions have been reported after exposure to arsenic, reduction 
and stimulation of cell survival and/or neurite outgrowth may occur simultaneously in different 
brain regions (Sánchez-Peña et al., 2010). Therefore, not only a decrease but also an increase in 
cell number and/or neurite outgrowth might be taken into account as a feature of arsenic adverse 
effects. The hypothesis that arsenic exerts its toxic effects through mechanisms that differ 
according to the brain regions will need to be tested in experimental animals in the future. 
 
5. Conclusions 
 In conclusion, exposure to arsenic at concentrations below the concentration that caused cell 
death in primary cultures of cortical neurons impaired neuritogenesis and we speculate that 
impaired neuritogenesis is partly due to reduction of GluA1 expression. By contrast, cell survival 
and GluA1 expression both increased when exposed to NaAsO2 concentrations below the 
concentrations that impaired neurite outgrowth. Future studies will be required to determine 
whether these findings in culture systems also occur in experimental animals in vivo. 
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F igure Legends 
F ig. 1. Effects of NaAsO2 on cell viability and neurite outgrowth in primary cultures of 
neurons. A . Cell viability was assessed using the WST-1 assay. Cell viability was significantly 
reduced by exposure to 2PM NaAsO2 (b, p<0.01 vs 0, 0.125, 0.25, 0.5, 1 PM). No significant 
decrease of cell viability was found between the exposures to 0 PM and 1PM NaAsO2. The 
exposure to 0.5PM NaAsO2 rather increased cell viability when compared to 0, 1 and 2 PM (a, 
p<0.01). B-E . Confocal images of neurons exposed to 0, 0.5, 1 and 2 PM NaAsO2 from DIV2 to 
4. F. Total neurite length of neurons exposed to 0, 0.5, 1 and 2 PM NaAsO2 from DIV2 to 4. A 
significant reduction of total neurite length per cell ZDVIRXQGDWȝ0(a, p<0.05 vs 0 PM and 
p<0.01 vs 0.5 PM) and the degree of reduction was more severe at 2 PM (b, p<0.01 vs 0 and 0.5 
PM). G . Total number of branches. H . Number of primary branches. I . The number of secondary 
and higher order branches. The number of secondary and higher order branches was significantly 
decreased in groups exposed to 1 PM or 2 µM NaAsO2 when compared to the group exposed to 
0.5 PM NaAsO2 (a, p<0.01 vs 1.0 and 2.0 PM), but there was no significant difference when 
compared to the group at 0 µM. 
 
F ig. 2. Effects of NaAsO2 on extracellular glutamate levels and expression of A MPA 
receptors. A . The concentration of glutamate in the culture medium of primary neurons had been 
exposed to NaAsO2 at concentrations of 0, 0.125, 0.25, 0.5, and 1 PM from DIV2 to DIV4. There 
was no difference in the concentrations of glutamate among groups. B . Immunoblot analyses of 
GluA1 and control E-actin expression levels. C . Quantification of optical density (O.D.) of bands 
revealed that GluA1 expression was significantly decreased by the exposure to 1 PM NaAsO2 (a, 
p<0.01 vs 0 PM and p<0.05 vs 0.5 PM) and the decrease became more severe by the exposure to 
2 PM NaAsO2 (b, p<0.01 vs 0 and 0.5 PM and p<0.05 vs 1.0 PM). D . Immunoblot analyses of 
AMPA receptors GluA1, 2/3 and 4 at the concentrations of 0 and 1 PM NaAsO2. MAP2 
andE-actin were used as controls. E . GluA1 levels were significantly decreased by the exposure 
to 1 PM NaAsO2 (a, p<0.01 vs 0 PM). GluA2/3 and GluA4 levels were unchanged. 
 
F ig. 3. Effect of NaAsO2 on GluA1 expression in primary-cultured NPY-hr G FP neurons. A . 
Macroscopic view of the cerebral cortex emitting green fluorescence from the transgenic mouse 
expressing a humanized Renilla green fluorescence protein (hrGFP) under the regulation of the 
neuropeptide Y (NPY) gene promoter (NPY-hrGFP). B . Immunocytochemistry of GluA1 in 
NPY-hrGFP neurons. Green indicates hrGFP-tagged NPY neuron. Red indicates 
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GluA1-immunoreactivity. Blue indicates 4',6-diamidino-2-phenylindole (DAPI) which reflects 
the nuclei. Arrows indicate the NPY-hrGFP and GluA1-double positive cells and arrowheads 
indicate GluA1-single positive cells. Most of NPY-hrGFP neurons shown here exhibited 
GluA1-immunoreactivity. C . Percentage of GluA1-positive neurons compared to total 
NPY-hrGFP neuron. 98.5% of NPY-hrGFP neurons were GluA1-positive D-G . Morphology of 
NPY-hrGFP neurons exposed to NaAsO2 at concentrations of 0, 0.5, 1 and 2 PM. H . Total neurite 
length of NPY-hrGFP neurons exposed to 0, 0.5, 1 and 2 PM NaAsO2 from DIV2 to DIV4. The 
length of neurites was significantly decreased at the exposure to 1 PM NaAsO2 (a, p<0.01 vs 1 
and 2 PM; b, p<0.05 vs 0 and 2 PM ; c, p< 0.01 vs 0 PM) and the decrease became more severe at 
2 PM NaAsO2. I . Effect of NaAsO2 on relative intensity of GluA1 immunoreactivity in 
NPY-hrGFP neuron. Relative intensity became significantly higher by the exposure to 0.5 PM 
NaAsO2 (a, p<0.01 vs 0, 1 and 2 PM). By contrast, the exposure to 1 PM NaAsO2 significantly 
reduced the relative intensity (b, p<0.01 vs 0 and 2 PM; c, p<0.01 vs 0 PM) and the exposure to 2 
PM NaAsO2 induced more important reduction. J. Effect of NaAsO2 on the relative intensity of 
GluA4 immunoreactivity in NPY-hrGFP neurons. Relative intensity of GluA4 immunoreactivity 
rather increased with the concentrations of NaAsO2 (a, p<0.01 vs 0 and 2 PM, p<0.05 vs 1 PM; b, 
p<0.01 vs 0 PM, p<0.05 vs 2 PM; c, p<0.01 vs 0 PM).  
 
F ig. 4. Effects of G luA1 overexpression on impaired neurite outgrowth induced by NaAsO2 
A-D . Effect of the combination of GluA1 overexpression and NaAsO2 treatment on neurite 
RXWJURZWK ³NaAsO2´ LQGLFDWHV the exposure to 2 PM NaAsO2 from DIV2 to DIV4 and 
³NaAsO2(-´ LQGLFDWHV no such exposure. ³GluA1(+´ indicates neurons transfected with 
pGFP-*OX$DQG³*OX$-´LQGLFDWHV neurons transfected with control pEGFP. E . Changes in 
total neurite length induced by the combination of GluA1 overexpression and NaAsO2 treatment. 
GluA1 overexpression significantly increased total neurite length of neurons with no NaAsO2 
treatment (a, p<0.01 vs other groups). The exposure to NaAsO2 significantly reduced total neurite 
length (b, p<0.05 vs NaAsO2(-)-GluA1(-) group) but GluA1 overexpression alleviated the 
inhibitory effects of NaAsO2 on neurite length (c, p<0.01 vs NaAsO2(-)-GluA1(+) and 
NaAsO2(+)-GluA1(-) groups). F. Total number of neurite branches. The treatment with NaAsO2 
significantly reduced the total number of branches and GluA1 overexpression tended to increase 
the total number of branches but the overexpression could not overcome the effect of NaAsO2 (a, 
p<0.01 vs NaAsO2 (+)-GluA1(-) group, p<0.05 vs NaAsO2 (+)GluA1(+) group; b, p<0.05 vs 
NaAsO2(-)-GluA1(-) group). G . The number of primary branches. No difference was found 
! #&!
among groups. H . The number of secondary and higher order branches. GluA1 overexpression 
increased the number in NaAsO2-untreated groups (a, p<0.01 vs other groups) but it could not 
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